%A Li Yan %T Effect of resveratrol on cisplatin chemotherapy sensitivity of ovarian cancer cells %0 Journal Article %D 2018 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2018.01.002 %P 5- %V 45 %N 1 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10379.shtml} %8 2018-01-08 %X ObjectiveTo investigate the effect and mechanism of resveratrol on cisplatin chemotherapy sensitivity of human epithelial ovarian cancer SKOV3 cells. MethodsThe cultured in vitro human ovarian cancer SKOV3 cells in logarithmic growth phase were treated with resveratrol (20 μg/ml), cisplatin (40 μg/ml) and resveratrol (20 μg/ml) + cisplatin (20 μg/ml) respectively, and the blank group was set, n=10. After 48 hours, the cellular growth inhibition rate was calculated by methyl thiazolyl thiazolium (MTT), cell cycle and apoptosis rate were analyzed by flow cytometry, the expressions of Bax mRNA and Bcl2 mRNA were detected by reverse transcriptionpolymerase chain reaction (RTPCR), and the expression of cleaved Caspase3 protein was detected by Western blotting. ResultsThe cellular growth inhibition rate of SKOV3 cells in resveratrol + cisplatin group was significantly increased than that in cisplatin group [(53.0±8.1)% vs. (37.5±6.5)%, P=0.017], the proportion of G0G1 phase cells in resveratrol + cisplatin group was significantly higher than that in cisplatin group [(61.2±3.4)% vs. (54.9±2.8)%, P=0.017], the proportion of G2M phase cells in resveratrol + cisplatin group was significantly lower than that in cisplatin group [(5.1±0.5)% vs. (8.6±0.9)%, P=0.008], the apoptosis index in resveratrol + cisplatin group was significantly increased than that in cisplatin group [(59.3±7.4)% vs. (43.6±6.0)%, P=0.015], the ratio of Bax/Bcl2 in resveratrol + cisplatin group was significantly increased than that in cisplatin group (4.6±1.8 vs. 3.3±1.4, P=0.026), and the expression of cleaved Caspase3 protein in resveratrol + cisplatin group was significantly increased than that in cisplatin group (0.47±0.15 vs. 0.38±0.12, P=0.011). Compared with blank group, the G0G1 phase in cell cycle of resveratrol group was significantly increased [(46.5±2.4)% vs. (37.8±1.9)%, P=0.023], the expression of Bcl2 mRNA was significantly decreased [(32.9±11.2) ×10-3 vs. (44.8±13.0)×10-3, P=0.028], the ratio of Bax/Bcl2 was significantly increased (2.1±0.8 vs. 1.5±0.6, P=0.019), and the expression of cleaved Caspase3 protein was significantly increased (0.26±0.10 vs. 0.08±0.03, P<0.001). ConclusionResveratrol can effectively enhance the effect on human epithelial ovarian cancer SKOV3 cells treated by cisplatin, which is perhaps related to its effects of blocking the cell cycle G0G1 and altering the expression of apoptosisrelated genes and proteins.